Drugs that inhibit tumor necrosis factor provide considerable benefit in treatment of rheumatoid arthritis; however, there is an unmet medical need for alternative therapies. Nature Clinical Practice Rheumatology
Dr. Mease reviews data presented at the ACR 2007 meeting on recent advances in fibromyalgia with a focus on mechanisms, clinical aspects, and safety and efficacy of treatments. Medscape Rheumatology
The optimal schedule for glucocorticoid therapy is discussed in addition to other treatments that may be used as glucocorticoid-sparing agents. Current Opinion in Rheumatology
